INTRODUCTION: Changes in circulating CD34+CD45low stem cells (SC) and CD34+CD45low+KDR+ endothelial progenitor cells (EPC) may reflect pathological endothelial activation. Non-pulsatile/continuous-flow left ventricular assist devices (CF-LVAD) can enhance this process. The aim of this study was to analyse the impact of 12-month CF-LVAD treatment on SC and EPC. METHODS: We analysed changes in SC and EPC from the pre-implantation period up until 12 months after implantation over 3-month intervals in 14 patients. Data from 12 patients with heart failure (HF) and from 13 healthy volunteers were used as controls. RESULTS: Baseline EPC were significantly higher in CF-LVAD and HF patients than in healthy controls, substantially decreasing 3 months after CF-LVAD implantation and then returning to high baseline values at 12 months. CONCLUSIONS: Changes in circulating SC and EPC may reflect pathological endothelial activation after CF-LVAD implantation.

2nd Department of Surgery Department of Cardiovascular Surgery 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Anesthesiology and Intensive Care Medicine 1st Faculty of Medicine Charles University and Military University Hospital Prague Czech Republic

Department of Internal Medicine 2nd Faculty of Medicine Charles University Czech Republic

Department of Physiology 3rd Faculty of Medicine Charles University Prague Czech Republic

Institute for Clinical and Experimental Medicine Prague Czech Republic

See more in PubMed

Horn P, Kelm M, Westenfeld R. Integration of medical therapy and mechanical circulatory support in the management of acute heart failure. Arch Med Sci. 2016;12:1317–23. PubMed PMC

Kirklin JK, Xie R, Cowger J, et al. Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry. J Heart Lung Transplant. 2018;37:685–91. PubMed

Witman MA, Garten RS, Giffort JR, et al. Further peripheral vascular dysfunction in heart failure patients with a continuous-flow left ventricular assist device: the role of pulsatility. JACC Heart Fail. 2015;3:703–11. PubMed PMC

Manginas A, Tsiavou A, Sfyrakis P, et al. Increased number of circulating progenitor cells after implantation of ventricular assist devices. J Heart Lung Transplant. 2009;28:710–7. PubMed

King TF, McDermott JH. Endothelial progenitor cells and cardiovascular disease. J Stem Cells. 2016;9:93–106. PubMed

Pokrywka A, Zembron-Lacny A, Baldy-Chudzik K, et al. The influence of hypoxic physical activity on cfDNA as a new biomarker of vascular inflammation. Arch Med Sci. 2015;11:1156–63. PubMed PMC

Kavala AA, Turkyilmaz S. Autogenously derived regenerative cell therapy for venous leg ulcers. Arch Med Sci Atheroscler Dis. 2018;3:156–63. PubMed PMC

Koller L, Hohensinner P, Sulzgruber P, et al. Prognostic relevance of circulating endothelial progenitor cells in patients with chronic heart failure. Thromb Haemost. 2016;116:309–16. PubMed

Ivak P, Pitha J, Wohlfahrt P, et al. Biphasic response in number of stem cells and endothelial progenitor cells after left ventricular assist device implantation: a 6-month follow-up. Int J Cardiol. 2016;218:98–103. PubMed

Netuka I, Kvasnička T, Kvasnička J, et al. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. J Heart Lung Transplant. 2016;35:860–7. PubMed

Increased pulsatility index is associated with adverse outcomes in left ventricular assist device recipients